Ming‐Hong Hao

2.2k total citations
32 papers, 1.1k citations indexed

About

Ming‐Hong Hao is a scholar working on Molecular Biology, Materials Chemistry and Organic Chemistry. According to data from OpenAlex, Ming‐Hong Hao has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Materials Chemistry and 6 papers in Organic Chemistry. Recurrent topics in Ming‐Hong Hao's work include Protein Structure and Dynamics (14 papers), Enzyme Structure and Function (10 papers) and Chemical Synthesis and Analysis (4 papers). Ming‐Hong Hao is often cited by papers focused on Protein Structure and Dynamics (14 papers), Enzyme Structure and Function (10 papers) and Chemical Synthesis and Analysis (4 papers). Ming‐Hong Hao collaborates with scholars based in United States, Italy and China. Ming‐Hong Hao's co-authors include Harold A. Scheraga, Wilma K. Olson, Ingo Muegge, Nathan K. Yee, Chris H. Senanayake, Stephen C. Harvey, Nitinchandra D. Patel, Guangqing Xu, Sonia Rodrı́guez and Bruce Z. Lu and has published in prestigious journals such as The Journal of Chemical Physics, Accounts of Chemical Research and Journal of Molecular Biology.

In The Last Decade

Ming‐Hong Hao

29 papers receiving 1.1k citations

Peers

Countries citing papers authored by Ming‐Hong Hao

Since Specialization

Citations

This map shows the geographic impact of Ming‐Hong Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Hong Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Hong Hao more than expected).

Fields of papers citing papers by Ming‐Hong Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Hong Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Hong Hao. The network helps show where Ming‐Hong Hao may publish in the future.

Co-authorship network of co-authors of Ming‐Hong Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Hong Hao. A scholar is included among the top collaborators of Ming‐Hong Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Hong Hao. Ming‐Hong Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 1659: ETX-636, a novel allosteric pan-mutant-selective PI3Kα dual inhibitor and degrader with best-in-class potential 2025 ·Cancer Research ·Robert F. Koncar, (unknown), Jingyan Gao, Fei Pang, Ying Lin, Raj Nagaraja, Yong Tang, (unknown), (unknown), Karan Kapoor, (unknown), Eric Simone, Ming‐Hong Hao, Shengfang Jin, Tao Liu, Meghana Kulkarni, Jeffery L. Kutok	0
2	Abstract P4-12-29: ETX-197/BG-68501, a potential best-in-class potent, selective, oral, small molecule CDK2 inhibitor, has anti-tumor activity in cancer models with Cyclin E amplification or deficiency in the Retinoblastoma 1 gene 2025 ·Clinical Cancer Research ·Daliya Banerjee, (unknown), Jingyan Gao, Fei Pang, (unknown), Raj Nagaraja, Yong Tang, Zhipeng Fan, (unknown), Ming‐Hong Hao, Shengfang Jin, Tao Liu, Tai‐Tong Wong	0
3	Estrogen Receptor Covalent Antagonists: The Best Is Yet to Come 2019 ·Cancer Research ·Craig Furman, Ming‐Hong Hao, Sudeep Prajapati, Dominic J. Reynolds, Victoria Rimkunas, Guo Zhu Zheng, Ping Zhu, Manav Korpal	26
4	Celecoxib is a substrate of CYP2D6: Impact on celecoxib metabolism in individuals with CYP2C93 variants 2018 ·Drug Metabolism and Pharmacokinetics* ·(unknown), Ming‐Hong Hao, Vaishali Dixit, (unknown)	21
5	Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies 2013 ·Journal of Medicinal Chemistry ·Steven J. Taylor, Anil K. Padyana, (unknown), Shuang Liang, Ming‐Hong Hao, Stéphane De Lombaert, John Proudfoot, Bennett Farmer, Xiang Li, (unknown), Leslie Martin, (unknown), (unknown), Steven S. Pullen, Hidenori Takahashi	23
6	Efficient Chiral Monophosphorus Ligands for Asymmetric Suzuki–Miyaura Coupling Reactions 2012 ·Organic Letters ·Wenjun Tang, Nitinchandra D. Patel, Guangqing Xu, Xiaobing Xu, Jolaine Savoie, Shengli Ma, Ming‐Hong Hao, (unknown), Andrew G. Capacci, Xudong Wei, Yongda Zhang, Joe Gao, Wenjie Li, Sonia Rodrı́guez, Bruce Z. Lu, Nathan K. Yee, Chris H. Senanayake	137
7	Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P1) region 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Jin‐Man Kim, Ming‐Hong Hao, Kevin Qian, Neil A. Farrow, (unknown), (unknown), Richard D. Schneiderman, Elias August, Leslie Martin, (unknown), Steven S. Pullen, Hidenori Takahashi, Stéphane De Lombaert	16
8	ChemInform Abstract: The Olefin Metathesis Reaction: Applications in the Pharmaceutical Industry 2010 ·ChemInform ·Vittorio Farina, Chutian Shu, Xingzhong Zeng, Ming‐Hong Hao, Xudong Wei, Nathan K. Yee, Carl A. Busacca, Zhengxu S. Han, Chris H. Senanayake	1
9	Synthesis and SAR studies of indole-based MK2 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Zhaoming Xiong, (unknown), Derek A. Cogan, Daniel R. Goldberg, Ming‐Hong Hao, Neil Moss, Edward J. Pack, (unknown), Donna Skow, Thomas Trieselmann, Brian Werneburg, André White	32
10	Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), David Thomson, Raj Betageri, (unknown), Ming‐Hong Hao, Eugene R. Hickey, Weimin Liu, Usha Patel, Yancey D. Ward, Erick R. R. Young, Richard M. Nelson, Alison Kukulka, Maryanne L. Brown, K. Crane, Della White, (unknown), Mark E. Labadia, (unknown), Denice M. Spero	10
11	Torsion Angle Preference and Energetics of Small-Molecule Ligands Bound to Proteins 2007 ·Journal of Chemical Information and Modeling ·Ming‐Hong Hao, (unknown), Ingo Muegge	72
12	Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), António Daniel Barbosa, (unknown), (unknown), Daniel R. Goldberg, Ming‐Hong Hao, Rachel Kroe‐Barrett, (unknown), Kevin Qian, (unknown), Christopher R. Sarko, (unknown), Neil Moss	21
13	Designing potential energy functions for protein folding 1999 ·Current Opinion in Structural Biology ·Ming‐Hong Hao, (unknown)	60
14	Molecular mechanisms for cooperative folding of proteins 1998 ·Journal of Molecular Biology ·Ming‐Hong Hao, Harold A. Scheraga	47
15	Absolute Stereochemistry of Soulattrolide and Its Analogues 1998 ·The Journal of Organic Chemistry ·(unknown), Athula B. Attygalle, Adam Liwo, Ming‐Hong Hao, Jerrold Meinwald, H.R.W. Dharmaratne, (unknown)	12
16	Optimizing Potential Functions for Protein Folding 1996 ·The Journal of Physical Chemistry ·Ming‐Hong Hao, Harold A. Scheraga	40
17	Active transport of ions across membranes: energetic role of electrostatics and binding site asymmetry 1995 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Ming‐Hong Hao, Stephen C. Harvey	2
18	Monte Carlo Simulation of a First-Order Transition for Protein Folding 1994 ·The Journal of Physical Chemistry ·Ming‐Hong Hao, Harold A. Scheraga	147
19	Analyzing the normal mode dynamics of macromolecules by the component synthesis method 1992 ·Biopolymers ·Ming‐Hong Hao, Stephen C. Harvey	18
20	Molecular Modeling and Energy Refinement of Supercoiled DNA 1989 ·Journal of Biomolecular Structure and Dynamics ·Ming‐Hong Hao, Wilma K. Olson	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact